Back
Fulcrum Therapeutics 10K Form
Sell
13
FULC
Fulcrum Therapeutics
Last Price:
$3.13
Seasonality Move:
-17.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FULC News And Ratings
See the #1 stock for the next 7 days that we like better than FULC
FULC Financial Statistics
Sales & Book Value
| Annual Sales: | $80M |
|---|---|
| Cash Flow: | $-17M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.50 |
| Price / Book: | 0.69 |
Profitability
| EPS (TTM): | -0.22000 |
|---|---|
| Net Income (TTM): | $-9.7M |
| Gross Margin: | -- |
| Return on Equity: | -8.07% |
| Return on Assets: | -7.42% |
Fulcrum Therapeutics Earnings Forecast
Key Fulcrum Therapeutics Financial Ratios
-
The Research & Development expenses have been 79.23% of Revenue.
-
The Net Earning history of FULC is -12.16% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 5 years.
Fulcrum Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | FULC |
| CUSIP: | 359616 |
| Website: | fulcrumtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 22.07 |
| Quick Ratio: | 21.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
FULC Technical Analysis vs Fundamental Analysis
Sell
13
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy or a Sell?
-
Fulcrum Therapeutics stock is rated a SellThe current Fulcrum Therapeutics [FULC] share price is $3.12. The Score for FULC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.